Low diurnal variability of apolipoprotein A1, apolipoprotein B and apolipoprotein B/apolipoprotein A1 ratio during normal sleep and after an acute shift of sleep

被引:4
作者
Larsson, Anders [1 ]
Carlsson, Lena [1 ]
Axelsson, John [2 ]
机构
[1] Uppsala Univ, Dept Med Sci, Sect Clin Chem, S-75185 Uppsala, Sweden
[2] Karolinska Inst, Psychol Sect, Dept Clin Neurosci, S-17176 Stockholm, Sweden
关键词
apolipoprotein A1; apolipoprotein B; diurnal variation; human;
D O I
10.1016/j.clinbiochem.2008.02.018
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: The aim of this study was to study the diurnal variation of the cardiovascular risk markers apolipoprotein A1 and B and apo B/apo A1 ratio. Design and methods: We have studied the diumal variation of apolipoprotein A1, apolipoprotein B and apo B/apo A1 ratio during night sleep and the day sleep conditions in seven healthy volunteers (age 22-32 yr). Samples were collected every hour to evaluate the effect of different sampling times on the test results. Results: The lowest diumal coefficient of variation (CV) was observed for the apo B/apo A1 ratio, which usually was below 2% but also apolipoprotein A1, apolipoprotein B showed low CV. There were no significant differences between nightsleep and daysleep, for any of the studied markers. Conclusion: Even if there was a diumal variation for these markers, the variation was very low. Thus, sampling does not have to be restricted to certain times of the day. (C) 2008 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:859 / 862
页数:4
相关论文
共 15 条
[1]   Effects of acutely displaced sleep on testosterone [J].
Axelsson, J ;
Ingre, M ;
Åkerstedt, T ;
Holmbäck, U .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (08) :4530-4535
[2]   Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel [J].
Barter, PJ ;
Ballantyne, CM ;
Carmena, R ;
Cabezas, MC ;
Chapman, MJ ;
Couture, P ;
De Graaf, J ;
Durrington, PN ;
Faergeman, O ;
Frohlich, J ;
Furberg, CD ;
Gagne, C ;
Haffner, SM ;
Humphries, SE ;
Jungner, I ;
Krauss, RM ;
Kwiterovich, P ;
Marcovina, S ;
Packard, CJ ;
Pearson, TA ;
Reddy, KS ;
Rosenson, R ;
Sarrafzadegan, N ;
Sniderman, AD ;
Stalenhoef, AF ;
Stein, E ;
Talmud, PJ ;
Tonkin, AM ;
Walldius, G ;
Williams, KMS .
JOURNAL OF INTERNAL MEDICINE, 2006, 259 (03) :247-258
[3]   Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk? [J].
Dean, BB ;
Borenstein, JE ;
Henning, JM ;
Knight, K ;
Merz, CNB .
AMERICAN HEART JOURNAL, 2004, 147 (06) :966-976
[4]   Medical lipid-regulating therapy - Current evidence, ongoing trials and future developments [J].
Evans, M ;
Roberts, A ;
Davies, S ;
Rees, A .
DRUGS, 2004, 64 (11) :1181-1196
[5]  
Huxley Rachel, 2002, Semin Vasc Med, V2, P315, DOI 10.1055/s-2002-35402
[6]  
Huynh H., 1976, J EDUC STATIST, V1, P69, DOI [DOI 10.3102/10769986001001069, 10.2307/1164736, DOI 10.2307/1164736]
[7]   Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes [J].
Jiang, R ;
Schulze, MB ;
Li, TC ;
Rifal, N ;
Stampfer, MJ ;
Rimm, EB ;
Hu, FB .
DIABETES CARE, 2004, 27 (08) :1991-1997
[8]   Monthly intra-individual variation in lipids over a 1-year period in 22 normal subjects [J].
Nazir, DJ ;
Roberts, RS ;
Hill, SA ;
McQueen, MJ .
CLINICAL BIOCHEMISTRY, 1999, 32 (05) :381-389
[9]  
NELSON W, 1979, CHRONOBIOLOGIA, V6, P305
[10]  
Rechtschaffen A., 1968, BRAIN INFORM SERVICE